Your browser doesn't support javascript.
loading
TP63-TRIM29 axis regulates enhancer methylation and chromosomal instability in prostate cancer.
Sultanov, R; Mulyukina, A; Zubkova, O; Fedoseeva, A; Bogomazova, A; Klimina, K; Larin, A; Zatsepin, T; Prikazchikova, T; Lukina, M; Bogomiakova, M; Sharova, E; Generozov, E; Lagarkova, M; Arapidi, G.
Afiliação
  • Sultanov R; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia. rhenium112@gmail.com.
  • Mulyukina A; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia. rhenium112@gmail.com.
  • Zubkova O; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
  • Fedoseeva A; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
  • Bogomazova A; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
  • Klimina K; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
  • Larin A; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
  • Zatsepin T; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
  • Prikazchikova T; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
  • Lukina M; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
  • Bogomiakova M; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
  • Sharova E; Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
  • Generozov E; Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
  • Lagarkova M; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
  • Arapidi G; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
Epigenetics Chromatin ; 17(1): 6, 2024 Mar 14.
Article em En | MEDLINE | ID: mdl-38481282
ABSTRACT

BACKGROUND:

Prostate adenocarcinoma (PRAD) is the second leading cause of cancer-related deaths in men. High variability in DNA methylation and a high rate of large genomic rearrangements are often observed in PRAD.

RESULTS:

To investigate the reasons for such high variance, we integrated DNA methylation, RNA-seq, and copy number alterations datasets from The Cancer Genome Atlas (TCGA), focusing on PRAD, and employed weighted gene co-expression network analysis (WGCNA). Our results show that only single cluster of co-expressed genes is associated with genomic and epigenomic instability. Within this cluster, TP63 and TRIM29 are key transcription regulators and are downregulated in PRAD. We discovered that TP63 regulates the level of enhancer methylation in prostate basal epithelial cells. TRIM29 forms a complex with TP63 and together regulates the expression of genes specific to the prostate basal epithelium. In addition, TRIM29 binds DNA repair proteins and prevents the formation of the TMPRSS2ERG gene fusion typically observed in PRAD.

CONCLUSION:

Our study demonstrates that TRIM29 and TP63 are important regulators in maintaining the identity of the basal epithelium under physiological conditions. Furthermore, we uncover the role of TRIM29 in PRAD development.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Limite: Humans / Male Idioma: En Revista: Epigenetics Chromatin Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Federação Russa País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Limite: Humans / Male Idioma: En Revista: Epigenetics Chromatin Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Federação Russa País de publicação: Reino Unido